Jump to main navigation | Jump to sub navigation | Jump to SiteMap | Jump to Home Page |
Latest News Releases
News and features
Epistem presents its new ex vivo plucked hair biomarker assay at EORTC-NCI-AACR symposiumEpistem plc today announced presentation of its novel ex vivo plucked hair biomarker assay at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium in Berlin on Friday 19th November. Epistem has developed a method for maintaining plucked human hairs ex vivo, and then treating with therapeutic agents to obtain valuable information on the cellular response to drug treatment.
18/11/2010
Epistem awarded further long term funding for NIH biodefence programmeEpistem plc announced today that it has been reappointed for up to five years to provide preclinical testing services as a subcontractor to the U.S. National Institutes of Health's (NIH) Radiation/Nuclear Medical Countermeasure Product Development Support Services Contract, which has been awarded to the University of Maryland School of Medicine (UMSOM) in Baltimore.
3/11/2010
Epistem to present data from their preclinical model of Crohn’s disease colitisEpistem plc will present preclinical results from its recently completed colitis study at the Inflammation Research Association (IRA) conference in Chantilly, Virginia USA between 26-29th September 2010. In a contracted study, Epistem successfully completed the testing of a number of neutralizing antibodies.
20/9/2010
Epistem announces agency agreement with Veritas JapanEpistem plc announced today that its Contract Research Services division has entered into an agreement with the Veritas Corporation to exclusively market and distribute Epistem's scientific research services in Japan.
2/9/2010
Epistem's Biomarker Division gains GCLP accreditationEpistem plc has announced today that their Biomarker Division has been awarded Good Clinical Laboratory Practice (GCLP) accreditation status.
7/6/2010
Epistem to launch RNA-Amp™ kits, for sensitive gene expression analysis, at AACR meetingEpistem will launch their RNA-Amp kits for mRNA expression amplification, at the American Association for Cancer Research Annual Meeting in Washington DC from April 18-21 2010.
16/4/2010
Epistem to present human plucked hair labelling platform at AACR meeting in Washington DCEpistem plc will present details of their new plucked hair immunohistochemistry platform at the American Association for Cancer Research Annual Meeting in Washington DC on Tuesday 20th April.
14/4/2010
Aeolus Pharmaceuticals Inc. initiates second study of lead drug AEOL 10150, conducted by EpistemAeolus Pharmaceuticals, Inc. announced today that a second study of its lead drug, AEOL 10150, has been initiated by the National Institutes of Health’s (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasures development program as a countermeasure for radiation exposure to the gastrointestinal (GI) tract.
12/4/2010
